Objective: To study the protective mechanism of captopril in diabetic cardiomyopathy by means of DNA microarray.
Methods: Rat models of diabetic cardiomyopathy were divided into test and control groups (n=5), and the rats in the test group were given oral captopril (1.5 mg/kg b.